查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945400

2026年全球介入性肿瘤器材市场报告

Interventional Oncology Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，介入性肿瘤器械市场成长显着，预计将从2025年的25亿美元成长到2026年的26.8亿美元，复合年增长率为7.1%。过去几年的成长可能归因于多种因素，例如癌症发生率的上升、介入放射学实践的扩展、影像技术的进步、微创癌症治疗的广泛应用以及专业癌症中心的建立。

预计未来几年介入肿瘤器械市场规模将强劲成长，2030年将达到35亿美元，复合年增长率（CAGR）为7.0%。预测期内的增长可归因于对标靶癌症治疗需求的不断增长、精准肿瘤学投资的增加、门诊癌症治疗机构的扩张、多学科介入疗法的日益普及以及消融和栓塞器械技术的进步。预测期内的主要趋势包括：影像导引肿瘤消融器材的日益普及、微创癌症治疗的广泛应用、栓塞疗法的日益普及、精准肿瘤学手术的扩展以及先进影像导引系统的日益整合。

预计未来几年，癌症的高发生率将推动介入肿瘤器械市场的成长。癌症是指一组疾病，其特征是异常细胞在体内不受控制地生长和扩散。这些异常细胞可形成肿瘤。癌症发生率的上升趋势正在推动对介入性肿瘤器械的需求。这些器材用于癌症的诊断、治疗和管理，有助于早期发现、分期和后续观察。例如，根据澳洲政府机构—澳洲健康与福利研究所 (AIHW) 于 2024 年 7 月发布的公告，该国癌症诊断数量预计将从 2022 年的 160,570 例增加到 2023 年的 164,694 例，同比增长显着。这一上升趋势证实了该国癌症发病率的上升。因此，癌症的高发生率正在促进介入性肿瘤器械市场的成长。

介入肿瘤器械市场的主要企业正致力于开发组织体积等先进技术，以提高肿瘤手术的诊断准确性和治疗效果。组织体积是切片检查过程中所采集的生物组织量。采集更多组织样本可获得更全面的信息，从而提高诊断准确性和治疗方案的有效性。例如，2023年6月，美国医疗设备製造商Argon Medical发布了半自动切片检查设备SuperCore Advantage。 SuperCore Advantage的样本采集量比主要企业的产品最多可多采集35%，从而减少了多次切片检查的需求。这一特性对于获取足够的组织样本以支持准确诊断至关重要。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球介入性肿瘤器材市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧与自主智能
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网 (IoT)、智慧基础设施和互联生态系统
  • 主要趋势
    • 影像导引肿瘤消融设备的应用日益广泛
    • 微创癌症治疗的日益普及
    • 栓塞疗法的应用日益广泛
    • 扩大精准肿瘤治疗程序
    • 增强先进图像支援系统的集成

第五章 终端用户产业市场分析

  • 医院
  • 癌症治疗中心
  • 专科肿瘤诊所
  • 介入放射中心
  • 大学医院

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球介入性肿瘤器材市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球介入性肿瘤器材市场规模、对比及成长率分析
  • 全球介入性肿瘤器材市场表现：规模与成长，2020-2025年
  • 全球介入性肿瘤器材市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 栓塞装置、消融装置、辅助装置
  • 按程式
  • 热消融术、非热消融术、经导管动脉化疗栓塞术 (TACE)、经导管动脉放射性栓塞术 (TARE)、选择性体内放射疗法(SIRT)、经导管动脉栓塞术 (TAE) 和品牌栓塞术
  • 按癌症类型
  • 肝癌、肾癌、肺癌、骨癌和其他类型的癌症
  • 依类型细分：栓塞装置
  • 栓塞剂、栓塞导管、栓塞剂输送系统
  • 按类型细分：消融设备
  • 射频消融装置、微波消融装置、冷冻消融装置、雷射消熔装置
  • 按类型细分：支援的设备
  • 影像导引系统、介入装置和流体管理系统

第十章 区域与国家分析

  • 全球介入性肿瘤器材市场：区域分析、预测及成长（2020-2025年、2025-2030年预测、2035年预测）
  • 全球介入性肿瘤器材市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 介入性肿瘤器材市场：竞争格局及市场占有率（2024年）
  • 介入性肿瘤器材市场：公司估值矩阵
  • 介入性肿瘤器材市场：公司概况
    • Boston Scientific Corporation
    • Terumo Corporation
    • Siemens Healthineers
    • Sirtex Medical Limited
    • AngioDynamics Inc.

第37章：其他领先和创新企业

  • Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS SA, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年介入肿瘤器材市场：提供新机会的国家
  • 2030年介入肿瘤器材市场：充满新机会的细分市场
  • 2030年介入性肿瘤器材市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MIODN02_G26Q1

Interventional oncology devices are specialized medical tools and technologies designed for the minimally invasive diagnosis and treatment of cancer. These devices enable direct targeting of tumors, allowing for treatments such as ablation or embolization, which focus on destroying cancer cells while preserving nearby healthy tissue.

The primary products within the field of interventional oncology devices include embolization devices, ablation devices, and support devices. Embolization devices are designed for the embolization of blood vessels associated with various tumors. These devices are employed in procedures such as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE), selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. These procedures are applied in the treatment of various cancer types, including liver cancer, kidney cancer, lung cancer, bone cancer, and others.

Tariffs are influencing the interventional oncology devices market by increasing costs of imported imaging systems, ablation probes, catheters, embolic materials, and electronic control components. Oncology centers and hospitals in North America and Europe are most affected due to reliance on specialized imported devices, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are increasing capital expenditure for cancer treatment facilities. However, they are also encouraging domestic device innovation, regional manufacturing expansion, and localized supply chain development for oncology technologies.

The interventional oncology devices market research report is one of a series of new reports from The Business Research Company that provides interventional oncology devices market statistics, including interventional oncology devices industry global market size, regional shares, competitors with a interventional oncology devices market share, detailed interventional oncology devices market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology devices industry. This interventional oncology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology devices market size has grown strongly in recent years. It will grow from $2.5 billion in 2025 to $2.68 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing cancer incidence rates, expansion of interventional radiology practices, improvements in imaging technologies, growing adoption of minimally invasive oncology treatments, availability of specialized oncology centers.

The interventional oncology devices market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing demand for targeted cancer therapies, rising investments in precision oncology, expansion of outpatient cancer treatment settings, growing adoption of combination interventional therapies, technological advancements in ablation and embolization devices. Major trends in the forecast period include increasing adoption of image-guided tumor ablation devices, rising use of minimally invasive cancer treatments, growing deployment of embolization therapies, expansion of precision oncology procedures, enhanced integration of advanced imaging support systems.

The high prevalence of cancer is anticipated to drive the growth of the interventional oncology devices market in the coming years. Cancer refers to a group of diseases marked by the uncontrolled growth and spread of abnormal cells within the body. These abnormal cells can form masses or tumors. The increasing prevalence of cancer raises the demand for interventional oncology devices, as they are used for the diagnosis, treatment, and management of cancer, supporting early detection, staging, and ongoing monitoring. For example, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of cancer cases diagnosed in Australia rose from 160,570 in 2022 to 164,694 in 2023, indicating a notable year-on-year increase. This upward trend underscores the growing prevalence of cancer in the country. Therefore, the high prevalence of cancer is contributing to the growth of the interventional oncology devices market.

Leading players operating in the interventional oncology devices market are emphasizing advanced technologies, such as tissue volume, to improve diagnostic precision and treatment effectiveness in oncology procedures. Tissue volume refers to the quantity of biological tissue obtained during a biopsy procedure. Collecting larger tissue volumes enables more comprehensive samples, thereby enhancing diagnostic accuracy and the effectiveness of treatment planning. For instance, in June 2023, Argon Medical, a US-based medical device company, introduced the SuperCore Advantage semi-automatic biopsy device. The SuperCore Advantage is capable of collecting up to 35% more samples compared to leading competitors, reducing the need for multiple biopsy passes. This capability is essential for obtaining sufficient tissue samples to support accurate diagnosis.

In May 2024, Siemens Healthineers, a Germany-based provider of devices and imaging systems supporting interventional oncology, entered into a partnership with University Hospitals to advance precision care through innovation and integrated clinical excellence. The collaboration aims to improve oncology, cardiovascular, and neurovascular outcomes by jointly advancing theranostics, novel MR technologies, and next-generation patient care solutions. University Hospitals is a US-based healthcare system.

Major companies operating in the interventional oncology devices market are Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, AngioDynamics Inc., Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation

North America was the largest region in the interventional oncology devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the interventional oncology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The interventional oncology devices market consists of sales of embolization devices, ablation devices, and support devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses interventional oncology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional oncology devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Embolization Devices; Ablation Devices; Support Devices
  • 2) By procedure: Thermal Tumor Ablation; Non-Thermal Tumor Ablation; Transcatheter Arterial Chemoembolization (TACE); Transcatheter Arterial Radioembolization (TARE); Selective Internal Radiation Therapy (SIRT); Transcatheter Arterial Embolization (TAE); Bland Embolization
  • 3) By Cancer Type: Liver Cancer; Kidney Cancer; Lung Cancer; Bone Cancer; Other Cancer Types
  • Subsegments:
  • 1) By Embolization Devices: Embolic Agents; Catheters For Embolization; Delivery Systems For Embolic Agents
  • 2) By Ablation Devices: Radiofrequency Ablation Devices; Microwave Ablation Devices; Cryoablation Devices; Laser Ablation Devices
  • 3) By Support Devices: Imaging Guidance Systems; Access Devices; Fluid Management Systems
  • Companies Mentioned: Boston Scientific Corporation; Terumo Corporation; Siemens Healthineers; Sirtex Medical Limited; AngioDynamics Inc.; Viant Medical; Medtronic plc; Olympus Corporation; Koninklijke Philips; Quantum Surgical; Profound Medical; Intuitive Surgical Inc; Cook Medical LLC; EDAP TMS S.A; Varian Medical Systems Inc; Heraeus Medical; ABLbio; Bioavlee; Mediceena International; LifeTech Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Interventional Oncology Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Interventional Oncology Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Interventional Oncology Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Interventional Oncology Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence And Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics And Precision Medicine
    • 4.1.3 Industry 4.0 And Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Image-Guided Tumor Ablation Devices
    • 4.2.2 Rising Use Of Minimally Invasive Cancer Treatments
    • 4.2.3 Growing Deployment Of Embolization Therapies
    • 4.2.4 Expansion Of Precision Oncology Procedures
    • 4.2.5 Enhanced Integration Of Advanced Imaging Support Systems

5. Interventional Oncology Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cancer Treatment Centers
  • 5.3 Specialty Oncology Clinics
  • 5.4 Interventional Radiology Centers
  • 5.5 Academic Medical Centers

6. Interventional Oncology Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Interventional Oncology Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Interventional Oncology Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Interventional Oncology Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Interventional Oncology Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Interventional Oncology Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Interventional Oncology Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Interventional Oncology Devices Market Segmentation

  • 9.1. Global Interventional Oncology Devices Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Embolization Devices, Ablation Devices, Support Devices
  • 9.2. Global Interventional Oncology Devices Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
  • 9.3. Global Interventional Oncology Devices Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
  • 9.4. Global Interventional Oncology Devices Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
  • 9.5. Global Interventional Oncology Devices Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
  • 9.6. Global Interventional Oncology Devices Market, Sub-Segmentation Of Support Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Imaging Guidance Systems, Access Devices, Fluid Management Systems

10. Interventional Oncology Devices Market Regional And Country Analysis

  • 10.1. Global Interventional Oncology Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Interventional Oncology Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Interventional Oncology Devices Market

  • 11.1. Asia-Pacific Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Interventional Oncology Devices Market

  • 12.1. China Interventional Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Interventional Oncology Devices Market

  • 13.1. India Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Interventional Oncology Devices Market

  • 14.1. Japan Interventional Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Interventional Oncology Devices Market

  • 15.1. Australia Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Interventional Oncology Devices Market

  • 16.1. Indonesia Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Interventional Oncology Devices Market

  • 17.1. South Korea Interventional Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Interventional Oncology Devices Market

  • 18.1. Taiwan Interventional Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Interventional Oncology Devices Market

  • 19.1. South East Asia Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Interventional Oncology Devices Market

  • 20.1. Western Europe Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Interventional Oncology Devices Market

  • 21.1. UK Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Interventional Oncology Devices Market

  • 22.1. Germany Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Interventional Oncology Devices Market

  • 23.1. France Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Interventional Oncology Devices Market

  • 24.1. Italy Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Interventional Oncology Devices Market

  • 25.1. Spain Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Interventional Oncology Devices Market

  • 26.1. Eastern Europe Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Interventional Oncology Devices Market

  • 27.1. Russia Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Interventional Oncology Devices Market

  • 28.1. North America Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Interventional Oncology Devices Market

  • 29.1. USA Interventional Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Interventional Oncology Devices Market

  • 30.1. Canada Interventional Oncology Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Interventional Oncology Devices Market

  • 31.1. South America Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Interventional Oncology Devices Market

  • 32.1. Brazil Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Interventional Oncology Devices Market

  • 33.1. Middle East Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Interventional Oncology Devices Market

  • 34.1. Africa Interventional Oncology Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Interventional Oncology Devices Market, Segmentation By Product, Segmentation By Procedure, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Interventional Oncology Devices Market Regulatory and Investment Landscape

36. Interventional Oncology Devices Market Competitive Landscape And Company Profiles

  • 36.1. Interventional Oncology Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Interventional Oncology Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Interventional Oncology Devices Market Company Profiles
    • 36.3.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. AngioDynamics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Interventional Oncology Devices Market Other Major And Innovative Companies

  • Viant Medical, Medtronic plc, Olympus Corporation, Koninklijke Philips, Quantum Surgical, Profound Medical, Intuitive Surgical Inc, Cook Medical LLC, EDAP TMS S.A, Varian Medical Systems Inc, Heraeus Medical, ABLbio, Bioavlee, Mediceena International, LifeTech Scientific Corporation

38. Global Interventional Oncology Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Interventional Oncology Devices Market

40. Interventional Oncology Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Interventional Oncology Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Interventional Oncology Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Interventional Oncology Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer